Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Intangibles (2016 - 2025)

Merit Medical Systems' Intangibles history spans 16 years, with the latest figure at $33.1 million for Q2 2025.

  • For Q2 2025, Intangibles fell 15.68% year-over-year to $33.1 million; the TTM value through Jun 2025 reached $33.1 million, down 15.68%, while the annual FY2024 figure was $66.5 million, 64.74% up from the prior year.
  • Intangibles for Q2 2025 was $33.1 million at Merit Medical Systems, down from $66.5 million in the prior quarter.
  • Across five years, Intangibles topped out at $108.4 million in Q1 2023 and bottomed at $831000.0 in Q2 2021.
  • The 5-year median for Intangibles is $39.2 million (2024), against an average of $36.6 million.
  • The largest annual shift saw Intangibles tumbled 88.11% in 2021 before it skyrocketed 980.58% in 2023.
  • A 5-year view of Intangibles shows it stood at $4.9 million in 2021, then soared by 683.45% to $38.4 million in 2022, then increased by 5.26% to $40.4 million in 2023, then surged by 64.74% to $66.5 million in 2024, then plummeted by 50.26% to $33.1 million in 2025.
  • Per Business Quant, the three most recent readings for MMSI's Intangibles are $33.1 million (Q2 2025), $66.5 million (Q4 2024), and $40.5 million (Q3 2024).